Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Surrogate Markers of Neutrophil Extracellular Trap Formation are Associated with Ischemic Outcomes and Platelet Activation after Peripheral Angioplasty and Stenting.

Demyanets S, Stojkovic S, Mauracher LM, Kopp CW, Wojta J, Thaler J, Panzer S, Gremmel T.

J Clin Med. 2020 Jan 22;9(2). pii: E304. doi: 10.3390/jcm9020304.

2.

Alternative activation of human macrophages enhances tissue factor expression and production of extracellular vesicles.

Hohensinner PJ, Mayer J, Kichbacher J, Kral-Pointner J, Thaler B, Kaun C, Hell L, Haider P, Mussbacher M, Schmid JA, Stojkovic S, Demyanets S, Fischer MB, Huber K, Wöran K, Hengstenberg C, Speidl WS, Oehler R, Pabinger I, Wojta J.

Haematologica. 2020 Jan 23. pii: haematol.2019.220210. doi: 10.3324/haematol.2019.220210. [Epub ahead of print]

3.

Liver-specific microRNA-122 as prognostic biomarker in patients with chronic systolic heart failure.

Stojkovic S, Koller L, Sulzgruber P, Hülsmann M, Huber K, Mayr M, Hengstenberg C, Wojta J, Niessner A.

Int J Cardiol. 2020 Mar 15;303:80-85. doi: 10.1016/j.ijcard.2019.11.090. Epub 2019 Nov 7.

PMID:
31757654
4.

MicroRNAs as Regulators and Biomarkers of Platelet Function and Activity in Coronary Artery Disease.

Stojkovic S, Nossent AY, Haller P, Jäger B, Vargas KG, Wojta J, Huber K.

Thromb Haemost. 2019 Oct;19(10):1563-1572. doi: 10.1055/s-0039-1693702. Epub 2019 Aug 17. Review.

PMID:
31421643
5.

The association of P2Y12 inhibitors with pro-coagulatory extracellular vesicles and microRNAs in stable coronary artery disease.

Haller PM, Stojkovic S, Piackova E, Andric T, Wisgrill L, Spittler A, Wojta J, Huber K, Jäger B.

Platelets. 2019 Aug 7:1-8. doi: 10.1080/09537104.2019.1648780. [Epub ahead of print]

PMID:
31389740
6.

Differential expression of Plg-RKT and its effects on migration of proinflammatory monocyte and macrophage subsets.

Thaler B, Baik N, Hohensinner PJ, Baumgartner J, Panzenböck A, Stojkovic S, Demyanets S, Huk I, Rega-Kaun G, Kaun C, Prager M, Fischer MB, Huber K, Speidl WS, Parmer RJ, Miles LA, Wojta J.

Blood. 2019 Aug 8;134(6):561-567. doi: 10.1182/blood.2018850420. Epub 2019 Jun 20.

7.

Course of platelet miRNAs after cessation of P2Y12 antagonists.

Jäger B, Stojkovic S, Haller PM, Piackova E, Kahl BS, Andric T, Vargas KG, Wojta J, Huber K.

Eur J Clin Invest. 2019 Aug;49(8):e13149. doi: 10.1111/eci.13149. Epub 2019 Jun 23.

PMID:
31172515
8.

Neutrophil Gelatinase Associated Lipocalin (NGAL) for Identification of Unstable Plaques in Patients with Asymptomatic Carotid Stenosis.

Eilenberg W, Stojkovic S, Kaider A, Piechota-Polanczyk A, Nanobachvili J, Domenig CM, Wojta J, Huk I, Demyanets S, Neumayer C.

Eur J Vasc Endovasc Surg. 2019 Jun;57(6):768-777. doi: 10.1016/j.ejvs.2018.12.029. Epub 2019 Jun 1.

PMID:
31164272
9.

The Relevance of Vascular Endothelial Growth Factor, Hypoxia Inducible Factor-1 Alpha, and Clusterin in Carotid Plaque Instability.

Basic J, Stojkovic S, Assadian A, Rauscher S, Duschek N, Kaun C, Wojta J, Falkensammer J.

J Stroke Cerebrovasc Dis. 2019 Jun;28(6):1540-1545. doi: 10.1016/j.jstrokecerebrovasdis.2019.03.009. Epub 2019 Apr 2.

PMID:
30952532
10.

The impact of age on cardiac function and extracellular matrix component expression in adverse post-infarction remodeling in mice.

Nagel F, Santer D, Stojkovic S, Kaun C, Schaefer AK, Krššák M, Abraham D, Bencsik P, Ferdinandy P, Kenyeres E, Szabados T, Wojta J, Trescher K, Kiss A, Podesser BK.

Exp Gerontol. 2019 May;119:193-202. doi: 10.1016/j.exger.2019.02.008. Epub 2019 Feb 11.

PMID:
30763602
11.

Defensive Implantable Cardioverter-Defibrillator Programming Is Safe and Reduces Inappropriate Therapy - Comparison of 3 Programming Strategies in 1,471 Patients.

Burger AL, Stojkovic S, Schmidinger H, Ristl R, Pezawas T.

Circ J. 2018 Nov 24;82(12):2976-2982. doi: 10.1253/circj.CJ-18-0611. Epub 2018 Sep 29.

12.

Cardioprotective cytokine interleukin-33 is up-regulated by statins in human cardiac tissue.

Pentz R, Kaun C, Thaler B, Stojkovic S, Lenz M, Krychtiuk KA, Zuckermann A, Huber K, Wojta J, Hohensinner PJ, Demyanets S.

J Cell Mol Med. 2018 Dec;22(12):6122-6133. doi: 10.1111/jcmm.13891. Epub 2018 Sep 14.

13.

Improved Propensity-Score Matched Long-Term Clinical Outcomes in Patients with Successful Percutaneous Coronary Interventions of Coronary Chronic Total Occlusion.

Stojkovic S, Juricic S, Dobric M, Nedeljkovic MA, Vukcevic V, Orlic D, Stankovic G, Tomasevic M, Aleksandric S, Dikic M, Tesic M, Mehmedbegovic Z, Boskovic N, Zivkovic M, Dedovic V, Milasinovic D, Ostojic M, Beleslin B.

Int Heart J. 2018 Jul 31;59(4):719-726. doi: 10.1536/ihj.17-360. Epub 2018 Jun 6.

14.

Long-term clinical outcomes after bioresorbable and permanent polymer drug-eluting stent implantation: final five-year results of the CENTURY II randomised clinical trial.

Wijns W, Valdes-Chavarri M, Richardt G, Moreno R, Íñiguez-Romo A, Barbato E, Carrié D, Ando K, Merkely B, Kornowski R, Eltchaninoff H, Stojkovic S, Saito S.

EuroIntervention. 2018 Jun 8;14(3):e343-e351. doi: 10.4244/EIJ-D-18-00358.

15.

Prognostic Value of Transthoracic Doppler Echocardiography Coronary Flow Velocity Reserve in Patients with Nonculprit Stenosis of Intermediate Severity Early after Primary Percutaneous Coronary Intervention.

Tesic M, Djordjevic-Dikic A, Giga V, Stepanovic J, Dobric M, Jovanovic I, Petrovic M, Mehmedbegovic Z, Milasinovic D, Dedovic V, Zivkovic M, Juricic S, Orlic D, Stojkovic S, Vukcevic V, Stankovic G, Nedeljkovic M, Ostojic M, Beleslin B.

J Am Soc Echocardiogr. 2018 Aug;31(8):880-887. doi: 10.1016/j.echo.2018.02.011. Epub 2018 Apr 3.

PMID:
29625885
16.

Chronic total occlusion percutaneous coronary intervention in clinical practice: novel grounds to be EXPLOREd.

Stojkovic S, Milasinovic D.

Heart. 2018 Sep;104(17):1392-1393. doi: 10.1136/heartjnl-2018-312940. Epub 2018 Mar 1. No abstract available.

PMID:
29496902
17.

GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2.

Stojkovic S, Kaider A, Koller L, Brekalo M, Wojta J, Diedrich A, Demyanets S, Pezawas T.

J Cell Mol Med. 2018 Apr;22(4):2422-2429. doi: 10.1111/jcmm.13540. Epub 2018 Feb 4.

18.

Circulating microRNAs identify patients at increased risk of in-stent restenosis after peripheral angioplasty with stent implantation.

Stojkovic S, Jurisic M, Kopp CW, Koppensteiner R, Huber K, Wojta J, Gremmel T.

Atherosclerosis. 2018 Feb;269:197-203. doi: 10.1016/j.atherosclerosis.2018.01.020. Epub 2018 Jan 16.

PMID:
29366993
19.

Predictive value of low interleukin-33 in critically ill patients.

Krychtiuk KA, Stojkovic S, Lenz M, Brekalo M, Huber K, Wojta J, Heinz G, Demyanets S, Speidl WS.

Cytokine. 2018 Mar;103:109-113. doi: 10.1016/j.cyto.2017.09.017. Epub 2017 Sep 30.

PMID:
28974430
20.

PAI-1 (Plasminogen Activator Inhibitor-1) Expression Renders Alternatively Activated Human Macrophages Proteolytically Quiescent.

Hohensinner PJ, Baumgartner J, Kral-Pointner JB, Uhrin P, Ebenbauer B, Thaler B, Doberer K, Stojkovic S, Demyanets S, Fischer MB, Huber K, Schabbauer G, Speidl WS, Wojta J.

Arterioscler Thromb Vasc Biol. 2017 Oct;37(10):1913-1922. doi: 10.1161/ATVBAHA.117.309383. Epub 2017 Aug 17.

21.

Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment.

Eilenberg W, Stojkovic S, Piechota-Polanczyk A, Kaider A, Kozakowski N, Weninger WJ, Nanobachvili J, Wojta J, Huk I, Demyanets S, Neumayer C.

Cardiovasc Diabetol. 2017 Aug 8;16(1):98. doi: 10.1186/s12933-017-0579-6.

22.

NGAL and MMP-9/NGAL as biomarkers of plaque vulnerability and targets of statins in patients with carotid atherosclerosis.

Eilenberg W, Stojkovic S, Kaider A, Kozakowski N, Domenig CM, Burghuber C, Nanobachvili J, Huber K, Klinger M, Neumayer C, Huk I, Wojta J, Demyanets S.

Clin Chem Lab Med. 2017 Nov 27;56(1):147-156. doi: 10.1515/cclm-2017-0156.

PMID:
28672747
23.

Endothelial Cell-derived Extracellular Vesicles Size-dependently Exert Procoagulant Activity Detected by Thromboelastometry.

Holnthoner W, Bonstingl C, Hromada C, Muehleder S, Zipperle J, Stojkovic S, Redl H, Wojta J, Schöchl H, Grillari J, Weilner S, Schlimp CJ.

Sci Rep. 2017 Jun 16;7(1):3707. doi: 10.1038/s41598-017-03159-0.

24.

Serbia: coronary and structural heart interventions from 2010 to 2015.

Stojkovic S, Milasinovic D, Bozinovic N, Davidovic A, Debeljacki D, Djenic N, Hinic S, Jagic N, Micic O, Mitov V, Neskovic AN, Nikolic M, Sagic D, Stankovic G.

EuroIntervention. 2017 May 15;13(Z):Z59-Z63. doi: 10.4244/EIJ-D-16-00829.

25.

IL-33 stimulates the release of procoagulant microvesicles from human monocytes and differentially increases tissue factor in human monocyte subsets.

Stojkovic S, Thulin Å, Hell L, Thaler B, Rauscher S, Baumgartner J, Gröger M, Ay C, Demyanets S, Neumayer C, Huk I, Spittler A, Huber K, Wojta J, Siegbahn A, Åberg M.

Thromb Haemost. 2017 Jun 28;117(7):1379-1390. doi: 10.1160/TH16-10-0784. Epub 2017 May 11. Erratum in: Thromb Haemost. 2017 Oct;117(10):2007.

PMID:
28492698
26.

Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up.

Wiemer M, Stojkovic S, Samol A, Dimitriadis Z, Ruiz-Nodar JM, Birkemeyer R, Monsegu J, Finet G, Hildick-Smith D, Tresukosol D, Novo EG, Koolen JJ, Barbato E, Danzi GB; NOBORI 2 investigators.

Cardiovasc Diabetol. 2017 May 4;16(1):59. doi: 10.1186/s12933-017-0541-7. No abstract available.

27.

Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure.

Koller L, Stojkovic S, Richter B, Sulzgruber P, Potolidis C, Liebhart F, Mörtl D, Berger R, Goliasch G, Wojta J, Hülsmann M, Niessner A.

JACC Heart Fail. 2017 Apr;5(4):268-277. doi: 10.1016/j.jchf.2016.12.008.

28.

Role of clinical pathway in improving the quality of care for patients with faecal incontinence: A randomised trial.

Hussain ZI, Lim M, Stojkovic S.

World J Gastrointest Pharmacol Ther. 2017 Feb 6;8(1):81-89. doi: 10.4292/wjgpt.v8.i1.81.

29.

Anti-thrombotic and pro-fibrinolytic effects of levosimendan in human endothelial cells in vitro.

Krychtiuk KA, Kaun C, Hohensinner PJ, Stojkovic S, Seigner J, Kastl SP, Zuckermann A, Eppel W, Rauscher S, de Martin R, Maurer G, Huber K, Wojta J, Speidl WS.

Vascul Pharmacol. 2017 Mar;90:44-50. doi: 10.1016/j.vph.2017.02.003. Epub 2017 Feb 10.

PMID:
28192257
30.

Moderate hyperoxia induces inflammation, apoptosis and necrosis in human umbilical vein endothelial cells: An in-vitro study.

Hafner C, Wu J, Soto-Gonzalez L, Kaun C, Stojkovic S, Wojta J, Tretter V, Markstaller K, Klein KU.

Eur J Anaesthesiol. 2017 Mar;34(3):141-149. doi: 10.1097/EJA.0000000000000593.

PMID:
28146458
31.

Resistance to DNA Damaging Agents Produced Invasive Phenotype of Rat Glioma Cells-Characterization of a New in Vivo Model.

Stojković S, Podolski-Renić A, Dinić J, Pavković Ž, Ayuso JM, Fernández LJ, Ochoa I, Pérez-García VM, Pešić V, Pešić M.

Molecules. 2016 Jun 27;21(7). pii: E843. doi: 10.3390/molecules21070843.

32.

Iatrogenic dissection of the left main coronary artery during elective diagnostic procedures--A report on three cases.

Djenić N, Dzudović B, Romanović R, Ratković N, Jović Z, Djukić B, Spasić M, Stojković S, Obradović S.

Vojnosanit Pregl. 2016 Mar;73(3):284-7.

PMID:
27295916
33.

Has the 'Fast-Track' referral system affected the route of presentation and/or clinical outcomes in patients with colorectal cancer?

Thornton L, Reader H, Stojkovic S, Allgar V, Woodcock N.

World J Surg Oncol. 2016 Jun 8;14(1):158. doi: 10.1186/s12957-016-0911-8.

34.

Interleukin-33 stimulates GM-CSF and M-CSF production by human endothelial cells.

Montanari E, Stojkovic S, Kaun C, Lemberger CE, de Martin R, Rauscher S, Gröger M, Maurer G, Neumayer C, Huk I, Huber K, Demyanets S, Wojta J.

Thromb Haemost. 2016 Aug 1;116(2):317-27. doi: 10.1160/TH15-12-0917. Epub 2016 May 12.

PMID:
27173404
35.

Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation.

Stojkovic S, Kaun C, Basilio J, Rauscher S, Hell L, Krychtiuk KA, Bonstingl C, de Martin R, Gröger M, Ay C, Holnthoner W, Eppel W, Neumayer C, Huk I, Huber K, Demyanets S, Wojta J.

Sci Rep. 2016 May 4;6:25171. doi: 10.1038/srep25171.

36.

MicroRNAs as circulating biomarkers in acute coronary syndromes: A review.

Ahlin F, Arfvidsson J, Vargas KG, Stojkovic S, Huber K, Wojta J.

Vascul Pharmacol. 2016 Jun;81:15-21. doi: 10.1016/j.vph.2016.04.001. Epub 2016 Apr 13. Review.

PMID:
27084396
37.

Percutaneous implantation of self-expandable aortic valve in high risk patients with severe aortic stenosis: The first experiences in Serbia.

Nedeljković MA, Beleslin B, Tesić M, Vukcević V, Stanković G, Stojković S, Orlić D, Bilbija I, Matković M, Simić T, Menković N, Mrdović I, Ussia GP, Perisić Z, Babić M.

Vojnosanit Pregl. 2016 Feb;73(2):192-7.

PMID:
27071288
38.

Neutrophil Gelatinase-Associated Lipocalin (NGAL) is Associated with Symptomatic Carotid Atherosclerosis and Drives Pro-inflammatory State In Vitro.

Eilenberg W, Stojkovic S, Piechota-Polanczyk A, Kaun C, Rauscher S, Gröger M, Klinger M, Wojta J, Neumayer C, Huk I, Demyanets S.

Eur J Vasc Endovasc Surg. 2016 May;51(5):623-31. doi: 10.1016/j.ejvs.2016.01.009. Epub 2016 Mar 2.

39.

Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives.

Stanković T, Dankó B, Martins A, Dragoj M, Stojković S, Isaković A, Wang HC, Wu YC, Hunyadi A, Pešić M.

Cancer Chemother Pharmacol. 2015 Sep;76(3):555-65. doi: 10.1007/s00280-015-2821-9. Epub 2015 Jul 22.

PMID:
26198315
40.

Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin.

Stojković S, Podolski-Renić A, Dinić J, Stanković T, Banković J, Hadžić S, Paunović V, Isaković A, Tanić N, Pešić M.

Exp Cell Res. 2015 Jul 15;335(2):248-57. doi: 10.1016/j.yexcr.2015.05.018. Epub 2015 May 27.

PMID:
26026740
41.

The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI.

Kostic J, Djordjevic-Dikic A, Dobric M, Milasinovic D, Nedeljkovic M, Stojkovic S, Stepanovic J, Tesic M, Trifunovic Z, Zamaklar-Tifunovic D, Radosavljevic-Radovanovic M, Ostojic M, Beleslin B.

Cardiovasc Ultrasound. 2015 May 27;13:26. doi: 10.1186/s12947-015-0020-9.

42.

CardioPulse: the 'Young Thrombosis Researchers Group' of the ESC Working Group on Thrombosis.

Grove EL, Lankeit M, Hess K, Freynhofer M, Stojkovic S, Varenhorst C, Thomas M.

Eur Heart J. 2015 Mar 21;36(12):703-4. No abstract available.

PMID:
25961094
43.

Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity.

Pešić M, Podolski-Renić A, Stojković S, Matović B, Zmejkoski D, Kojić V, Bogdanović G, Pavićević A, Mojović M, Savić A, Milenković I, Kalauzi A, Radotić K.

Chem Biol Interact. 2015 May 5;232:85-93. doi: 10.1016/j.cbi.2015.03.013. Epub 2015 Mar 24.

PMID:
25813935
44.

T-wave variability for the prediction of fast ventricular arrhythmias – prospective, observer-blind study.

Stojkovic S, Ristl R, Moser FT, Wolzt M, Wojta J, Schmidinger H, Pezawas T.

Circ J. 2015;79(2):318-24. doi: 10.1253/circj.CJ-14-1028. Epub 2014 Dec 5.

45.

ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: a patient-level meta-analysis of randomized trials.

Cassese S, De Luca G, Ribichini F, Cernigliaro C, Sansa M, Versaci F, Proietti I, Stankovic G, Stojkovic S, Fernandez-Pereira C, Tomai F, Vassanelli C, Antoniucci D, Serruys PW, Kastrati A, Rodriguez AE.

Atherosclerosis. 2014 Dec;237(2):410-7. doi: 10.1016/j.atherosclerosis.2014.09.021. Epub 2014 Sep 30.

PMID:
25463066
46.

Prolonged survival after neoadjuvant chemotherapy related with specific molecular alterations in the patients with nonsmall-cell lung carcinoma.

Stojsic J, Stankovic T, Stojkovic S, Milinkovic V, Dinic J, Milosevic Z, Milovanovic Z, Tanic N, Bankovic J.

Exp Mol Pathol. 2015 Feb;98(1):27-32. doi: 10.1016/j.yexmp.2014.11.010. Epub 2014 Nov 20.

PMID:
25449334
47.

Reduced sirolimus systemic exposure and improved bioresorbable polymer properties: new allies for the treatment of patients with coronary artery disease.

Stojkovic S, Neskovic AN, Mehmedbegovic Z, Kafedzic S, Ostojic M, Nedeljkovic M, Orlic D, Ilisic B, Ilic I, Aleksic A, Cerovic M, Nikolajevic I, Vlahovic-Stipac A, Stajic Z, Putnikovic B, Hamilos M.

Fundam Clin Pharmacol. 2015 Feb;29(1):95-105. doi: 10.1111/fcp.12092. Epub 2014 Dec 11.

PMID:
25223651
48.

Selection for atrial fibrillation ablation: Importance of diastolic function grading.

Pezawas T, Binder T, Ristl R, Schneider B, Stojkovic S, Schukro C, Schmidinger H.

J Cardiol. 2015 Jun;65(6):479-86. doi: 10.1016/j.jjcc.2014.07.018. Epub 2014 Aug 26.

49.

Antioxidative activity of diarylheptanoids from the bark of black alder (Alnus glutinosa) and their interaction with anticancer drugs.

Dinić J, Novaković M, Podolski-Renić A, Stojković S, Mandić B, Tešević V, Vajs V, Isaković A, Pešić M.

Planta Med. 2014 Aug;80(13):1088-96. doi: 10.1055/s-0034-1382993. Epub 2014 Aug 19.

PMID:
25137576
50.

CO2 acquisition in Chlamydomonas acidophila is influenced mainly by CO2, not phosphorus, availability.

Spijkerman E, Stojkovic S, Beardall J.

Photosynth Res. 2014 Sep;121(2-3):213-21. doi: 10.1007/s11120-014-0016-6. Epub 2014 Jun 7.

PMID:
24906887

Supplemental Content

Loading ...
Support Center